Robert Lamm
Keine laufenden Positionen mehr
Profil
Robert Lamm joined Savient Pharmaceuticals, Inc. in June 2002 as Vice President of Worldwide Quality Assurance and was appointed Senior Vice President of Quality and Regulatory Affairs in February 2006.
Prior to joining Savient Pharmaceuticals, he served as a Consultant for Quantic Consulting, Inc. from 2001 to 2002.
He worked for Carter-Wallace, Inc. from 1987 to 2001, most recently as Vice President of Corporate Quality Standards.
From 1984 to 1987, Dr. Lamm was Quality Section Head for Bristol-Myers Squibb Corp.
He received an MS degree in 1981 and a PhD in 1984 from Rutgers University.
Ehemalige bekannte Positionen von Robert Lamm
| Unternehmen | Position | Ende |
|---|---|---|
| SAVIENT PHARMACEUTICALS INC | General Counsel | 12.02.2009 |
MedPointe, Inc.
 MedPointe, Inc. Pharmaceuticals: MajorHealth Technology MedPointe, Inc. develops, markets, and sells therapeutics. The company's products include respiratory, allergy, central nervous system, cough/cold, and pediatric products. The company was founded by James S. Burns and Anthony H. Wild in 2001 and is headquartered in Somerset, NJ. | Corporate Officer/Principal | 01.01.2001 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.01.1987 |
Ausbildung von Robert Lamm
| Rutgers State University of New Jersey | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
MedPointe, Inc.
MedPointe, Inc. Pharmaceuticals: MajorHealth Technology MedPointe, Inc. develops, markets, and sells therapeutics. The company's products include respiratory, allergy, central nervous system, cough/cold, and pediatric products. The company was founded by James S. Burns and Anthony H. Wild in 2001 and is headquartered in Somerset, NJ. | Health Technology |
